LRMR Larimar Therapeutics

Watchlist

2.370
-0.180-7.06%

Close Mar 18 16:00 ET

2.370
0.0000.00%

Post 17:59 ET

151.22MMarket Cap-2.06P/E (TTM)

About Larimar Therapeutics Company

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Company Profile

SymbolLRMR

Company NameLarimar Therapeutics

Listing DateJun 19, 2014

Issue Price16.00

Founded2005

CEODr. Carole Ben-Maimon, M.D.

MarketNASDAQ

Employees42

Fiscal Year Ends12-31

Address3 Bala Plaza East,Suite 506

CityBala Cynwyd

ProvincePennsylvania

CountryUnited States of America

Zip Code19004

Phone1-844-511-9056

Websitehttp://larimartx.com

Company Executives

Name
Position
Salary

Dr. Carole Ben-Maimon, M.D.
Director, President and Chief Executive Officer
3.14M

Dr. Gopi Shankar, F.A.A.P.,M.B.A.,PhD
Chief Development Officer
1.38M

Dr. Russell G. Clayton, D.O.
Chief Medical Officer
--

Michael Celano
Chief Financial Officer and Principal Accounting Officer
1.42M

Joseph Truitt
Chairman of the Board
114.96K

Frank E. Thomas
Independent Director
86.21K

Dr. Jeffrey W. Sherman, F.A.C.P.,M.D.
Independent Director
56.43K

Thomas Edward Hamilton
Independent Director
77.77K

Jonathan S. Leff
Independent Director
79.96K

LRMR Larimar Therapeutics

About Larimar Therapeutics Company

Company Profile

Company Executives

Trending Stocks